Church Lab CRISPR Spinout eGenesis Lands $38M in Series A Financing | GenomeWeb

NEW YORK (GenomeWeb) – A startup from Harvard University's George Church looking to apply genome engineering to cross-species organ transplantation has raised $38 million in Series A financing.

Biomatics Capital and Arch Venture Partners led the round, joined by Khosla Ventures, Alta Partners, Alexandria Equities, Heritage Provider Network, Berggruen Holdings North America, Uprising, and Fan Ventures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.